About ChromaCon
ChromaCon AG is a biopharmaceutical company that develops and markets high performance bioprocess solution for the biopharmaceutical industry.
Its ContiChrom technology platform (using the patented MCSGP technology) is based on continuous chromatography, a powerful tool for the economic purification of components from complex mixtures, enabling the development of previously not accessible novel biological medicines and life cycle products with improved characteristics.
For high volume products, high throughput (productivity) can be set operationally offering the only high performance chromatographic method that is capable to handle very large process streams.
ChromaCon offers three product lines covering all process scales:
ChromaCon currently markets its ContiChrom labscale equipment worldwide through marketing partners who also provide after-sales and maintenance services.
- the ContiChrom labscale unit is used in discovery, pre-clinical and early clinical development
- the ContiChrom pilot-scale unit is used for production of API for clinical development and marketed products.
- the ContiChrom production-scale unit is customized based on the customer's process needs.
ChromaCon's strategy is to introduce its ContiChrom technology platform as a missing link and gold standard to the biopharmaceutical process chain, effectively linking high upstream output with downstream processivity.
